Regarding the risk factors of rituximab‐induced thrombocytopenia in patients with autoimmune bullous diseases
The Journal of Dermatology · 2024
DOI: 10.1111/1346-8138.17262 ↗Kurz gefasst
Leserbrief in der Zeitschrift The Journal of Dermatology, 2024. Verfasst von Jiangling Zheng. Beteiligte Einrichtung: Department of Dermatology, Hangzhou Third People's Hospital, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Rituximab, Thrombocytopenia, Skin Diseases, Vesiculobullous. Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Hangzhou Third People's Hospital, Hangzhou, Zhejiang, China.
ORCID-Profile: Jiangling Zheng
Zitieren
APA
Zheng, J. (2024). Regarding the risk factors of rituximab‐induced thrombocytopenia in patients with autoimmune bullous diseases. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.17262
Vancouver
Zheng J. Regarding the risk factors of rituximab‐induced thrombocytopenia in patients with autoimmune bullous diseases. The Journal of Dermatology. 2024. doi:10.1111/1346-8138.17262
BibTeX
@article{Zheng2024,
author = {Zheng, Jiangling},
title = {Regarding the risk factors of rituximab‐induced thrombocytopenia in patients with autoimmune bullous diseases},
journal = {The Journal of Dermatology},
year = {2024},
doi = {10.1111/1346-8138.17262}
}
EUVIMED